Tebra Secures $250M to Expand AI Capabilities for Private Medical Practices

Tebra, a California-based healthcare technology company, has raised $250M in new financing to accelerate the use of artificial intelligence across its platform for independent medical practices. The funding consists of a mix of equity and debt, with Hildred CapitalDealroom has a profile for this one. Try Dealroom → leading the equity investment and a debt facility provided by J.P. MorganDealroom has a profile for this one. Try Dealroom →.

The financing is intended to support expanded research and product development, with a focus on reducing administrative workload and improving operational efficiency for healthcare providers.

Formed through the merger of Kareo and PatientPop, Tebra offers an integrated suite of tools covering electronic health records, billing, scheduling, patient engagement and analytics.

The company serves tens of thousands of providers, positioning itself as a single platform for practices that have traditionally relied on fragmented software systems.

The latest raise includes a combination of equity and debt financing and brings in new and existing investors. Tebra has said the capital will be directed toward AI-driven features such as clinical documentation support, automated billing and enhanced patient communication, areas where practices face persistent time and cost pressures.

Tebra’s leadership has pointed to growing demand for technology that allows clinicians to spend less time on paperwork and more time on patient care. While the company has not disclosed updated financial metrics alongside the funding, it previously reached a valuation above $1bn following a financing round in 2022.

Sources:
Tebra
Business Wire
Pulse 2.0
FinSMEs

J.V.